Your browser doesn't support javascript.
loading
Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity.
Li, Dapeng; Brackenridge, Simon; Walters, Lucy C; Swanson, Olivia; Harlos, Karl; Rozbesky, Daniel; Cain, Derek W; Wiehe, Kevin; Scearce, Richard M; Barr, Maggie; Mu, Zekun; Parks, Robert; Quastel, Max; Edwards, Robert J; Wang, Yunfei; Rountree, Wes; Saunders, Kevin O; Ferrari, Guido; Borrow, Persephone; Jones, E Yvonne; Alam, S Munir; Azoitei, Mihai L; Gillespie, Geraldine M; McMichael, Andrew J; Haynes, Barton F.
  • Li D; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Brackenridge S; Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Walters LC; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
  • Swanson O; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
  • Harlos K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Rozbesky D; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
  • Cain DW; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
  • Wiehe K; Department of Cell Biology, Charles University, Prague, 12800, Czech Republic.
  • Scearce RM; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Barr M; Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Mu Z; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Parks R; Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Quastel M; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Edwards RJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Wang Y; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Rountree W; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Saunders KO; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
  • Ferrari G; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Borrow P; Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Jones EY; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Alam SM; Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Azoitei ML; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Gillespie GM; Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
  • McMichael AJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
  • Haynes BF; Department of Immunology, Duke University School of Medicine, Durham, NC, 27710, USA.
Commun Biol ; 5(1): 271, 2022 03 28.
Article en En | MEDLINE | ID: mdl-35347236
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígenos de Histocompatibilidad Clase I / Citotoxicidad Inmunológica Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígenos de Histocompatibilidad Clase I / Citotoxicidad Inmunológica Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article